June 11, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
An MS disease activity score test was found to be effective in monitoring underlying disease activity specific to disease-modifying therapies, according to an exploratory analysis.This finding, presented as a poster at the Consortium of Multiple Sclerosis Centers Annual Meeting, suggests the Octave Multiple Sclerosis Disease Activity (MSDA) Test could help clinicians more effectively adapt
June 11, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

CHICAGO — Most patients with early active relapsing-remitting MS treated with ocrelizumab did not see worse hand function or…

The Multiple Sclerosis Association of America (MSAA) Expands National Reach of Research Initiative to More than 1,000…

CHICAGO — An app that actively monitors symptoms and provides self-management advice could significantly improve quality of life…

DESTIN, Fla. — Most patients with systemic sclerosis require treatment with multiple modes of action, according to a presenter at…

We are living in an exciting new era for Alzheimer’s treatment. For the first time, therapies can slow the disease for some…

In this Healio video, Christopher Lock, MD, discusses advances in Alzheimer’s disease treatment and diagnosis presented at the…